

Eiger is a biopharmaceutical company developing new antiviral agents against novel targets in the treatment of hepatitis. Among its major competitors, Eiger BioPharmaceuticals is ranked in 6th place for NPS while Biogen is 1st, and Achillion Pharmaceuticals is 2nd.